Back to today’s briefing

Story perspectives

Blue Jays Sign Nic Enright, Eyes 2027 Comeback

1/1/2026

30 5 Full Breakdown

Summary

Story summary

The Toronto Blue Jays signed pitcher Nic Enright to a two-year minor league deal, but he will miss the 2026 season due to Tommy John surgery.
Enright previously battled Stage 2 Hodgkin lymphoma and posted a 2.03 ERA in 2025.
He will spend 2026 rehabilitating and aims to return in 2027.
The Blue Jays view this signing as a strategic move to strengthen their bullpen for the future.

History

Historical Context

In 1974, Dr. Frank Jobe performed the first ulnar collateral ligament reconstruction, known as Tommy John surgery, on pitcher Tommy John, who faced a career-threatening injury. This innovative procedure has since transformed player rehabilitation, with over 30,000 surgeries performed by 2020, allowing many athletes, including Nic Enright, to extend their careers and reshape team strategies in professional sports.

1 of 2

Story summary

The Toronto Blue Jays signed pitcher Nic Enright to a two-year minor league deal, but he will miss the 2026 season due to Tommy John surgery.
Enright previously battled Stage 2 Hodgkin lymphoma and posted a 2.03 ERA in 2025.
He will spend 2026 rehabilitating and aims to return in 2027.
The Blue Jays view this signing as a strategic move to strengthen their bullpen for the future.

1 / 2